D-Dimer-to-Albumin Ratio: A Novel Indicator to Predict Poor Outcomes in Patients with HBV-Associated Decompensated Cirrhosis
Table 3
Clinical data according to DAR values.
Low group (DAR >1.07, )
High group (DAR ≤1.07, )
Gender (female/male)
10/42
20/100
0.851
Age (years)
51.5 (44.0-57.5)
50.0 (42.0-59.0)
0.506
Total protein (g/dL)
5.89 (5.55-6.40)
5.83 (5.33-6.26)
0.146
Albumin (g/dL)
2.84 (2.40-3.10)
3.10 (2.86-3.48)
<0.001
ALT (U/L)
40.5 (30.0-143.5)
77.5 (29.0-223.0)
0.101
AST (U/L)
72.5 (45.0-128.5)
73.0 (41.0-155.5)
0.901
Total bilirubin (μmol/L)
137.0 (50.5-333.2)
216.5 (39.0-347.0)
0.681
INR
1.69 (1.46-2.19)
1.45 (1.24-1.72)
<0.001
Serum creatinine (μmol/L)
66.0 (57.0-94.5)
66.0 (57.5-78.0)
0.324
D-dimer (mg/L)
4.36 (3.82-6.12)
1.33 (0.64-2.20)
<0.001
Platelet (×109/L)
82.5 (52.5-130.0)
83.5 (55.0-114.5)
0.899
MELD score
18.2 (14.5-23.3)
15.8 (10.4-20.6)
0.010
30-day mortality (yes/no)
21/31
13/107
<0.001
Data are expressed as number, or median (interquartile range). Abbreviations: ALT: alanine aminotransferase; AST: aspartate aminotransferase; DAR: D-dimer-to-albumin ratio; INR: international normalized ratio; MELD: Model for End-Stage Liver Disease.
